Claims for Patent: 7,795,447

Summary for Patent: 7,795,447

Title:	Imidazole compounds for the treatment of neurodegenerative disorders
Abstract:	The present invention relates to compounds of the Formula I wherein R1, R2, R3, R4, R6, R7 and A are as defined. Compounds of the Formula I have activity inhibiting production of Aβ-peptide. The invention also relates to pharmaceutical compositions and methods for treating diseases and disorders, for example, neurodegenerative and/or neurological disorders, e.g., Alzheimer's disease, in a mammal comprising compounds of the Formula I.
Inventor(s):	Michael A. Brodney, Karen J. Coffman
Assignee:	Pfizer Corp SRL, Pfizer Inc
Application Number:	US11/971,272
Patent Claims:	1. A compound which is or a pharmaceutically acceptable salt thereof. 2. A pharmaceutical composition, comprising a therapeutically effective amount of a compound according to claim 1, or a pharmaceutically acceptable salt thereof, and a pharmaceutically acceptable carrier. 3. A compound which is or a pharmaceutically acceptable salt thereof. 4. A pharmaceutical composition, comprising a therapeutically effective amount of a compound according to claim 3, or a pharmaceutically acceptable salt thereof, and a pharmaceutically acceptable carrier. 5. A compound which is or a pharmaceutically acceptable salt thereof. 6. A pharmaceutical composition, comprising a therapeutically effective amount of a compound according to claim 5, or a pharmaceutically acceptable salt thereof, and a pharmaceutically acceptable carrier.